Home				Skin Diseases Drug Development - Y2007 week 02
DATE	SOURCE	OTHER PARTY INVOLVED	INDICATION(S)	HEADLINES - CLICK TO VIEW FULL RELEASE
01/12/07	Barrier Therapeutics (US)		Solar lentigines	Recent Study Shows Favorable Results of Solagé(R) (mequinol 2%, tretinoin 0.01%) Topical Solution for the Treatment of Solar Lentigines in…
01/10/07	AnGes MG (JP)	Vical (US)	Melanoma	AnGes MG, Vical to Start Phase III Clinical Trial of Allovectin for Gene Therapy
01/10/07	Basilea Pharmaceutica (CH)	J&J Cilag (US)	Skin infections	Basilea Announces Positive Top-line Results on Second Pivotal Phase III Ceftobiprole Trial
01/10/07	Viralytics (AU)		Melanoma	Ethics Committee Approval to conduct a Phase I study in Breast, Prostate and Melanoma Cancer patients using CAVATAKTM administered...
01/09/07	Aida Pharmaceuticals (CN)	Shanghai Qiaer Biotechnology (CN)	Melanoma	Aida Pharmaceuticals Receives Approval and Commences Phase II Trials of Potential Cancer Treatment
01/09/07	Quest PharmaTech (CA)		Hair removal	Quest PharmaTech Initiates a Fifty Patient Pivotal Clinical Trial for Cosmetic Hair Removal Applications
01/08/07	CombinatoRx (US)		Various	CombinatoRx Announces Portfolio Advancements
01/08/07	Human Genome Sciences (US)		Systemic lupus erythematosus	Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2007 Goals…
01/08/07	Incyte (US)		Psoriasis	Incyte to Report Positive Preliminary Clinical Results from HIV and Diabetes Programs and Highlight Progress in Several Drug Development…